[1]
“DETERMINATION OF ATORVASTATIN CALCIUM IN PHARMACEUTICAL FORMULATIONS BY REVERSE PHASE-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY”, Int J of Adv in Phar Ana, vol. 1, no. 2, pp. 48–53, Jan. 2012, doi: 10.7439/ijapa.v1i2.6.